期刊文献+

吡那地尔、美托洛尔、谷氨酰胺、胰岛素单独及联合使用对H9c2心肌细胞缺氧/复氧损伤的保护作用及机制

Protective Effects and Mechanism of Pinacidil,Metoprolol,Glutamine,Insulin Single and Combination Thearpy on H9c2 Cardiac Myocytes Exposed to Simulated Hypoxia/Reoxygenation
原文传递
导出
摘要 目的研究吡那地尔(pinacidil,Pin)、美托洛尔(metoprolol,Met)、谷氨酰胺(glutamine,Glu)、胰岛素(insulin,Ins)四药联用对缺氧/复氧(hypoxia/reoxygenation,H/R)所致H9c2心肌细胞损伤的保护作用并探讨其作用机制。方法将培养的H9c2心肌细胞随机分为7组,即①正常对照(Con)组;②H/R组;③Pin组;④Met组;⑤Glu组;⑥Ins组;⑦四药联用(PMGI)组。测定各组H9c2心肌细胞的存活率;收集培养液测定乳酸脱氢酶(lactate dehydrogenase,LDH)活性,超氧化物歧化酶(superoxide dismutase,SOD)活性;Western印迹法检测保护性蛋白热休克蛋白70(heat shock protein 70,HSP70)的表达情况。结果对于H/R损伤的H9c2心肌细胞,四药联用组与药物单用组或H/R组相比能明显提高细胞存活率,保护细胞膜,减少LDH渗漏;增加抗氧化能力,提高SOD含量;增加HSP70的表达。结论联合用药组与药物单用组相比保护作用增强。 OBJECTIVE To investigate protective effects and mechanism of pinacidil(Pin), metoprolol(Met), glutamine (Glu), insulin(Ins) on H9c2 cardiacmyocytes exposed to simulated hypoxia/reoxygenation(H/R). METHODS H9c2 cardiacmyocytes were randomly divided into seven groups: (1)control group; (2)H/R group; (3)Pin group; (4)Met group; (5)Glu group; (6)Ins group; (7)Pin + Met + Glu + Ins (PMGI) group. The survival rates of cardiomyocytes were detected. The activity of lactate dehydrogenase (LDH) and superoxide dismutase (SOD) in the culture medium were measured. Western blot was performed to examine expression of heat shock protein 70 (HSP70) in cardiomyocytes respectively. RESULTS The combination therapy of PMGI can protect the H9c2 cardiac cell membrane caused by hypoxia/reoxygenation injury; increase cell survival rate, decrease LDH leakage, protect cardiac cell against H/R injury through elevating T-SOD and Mn-SOD activity, increase the expression of HSP70. CONCLUSION Compared to the individual group, drug combination treatment enhances protective effects.
出处 《中国现代应用药学》 CAS CSCD 2012年第3期191-194,共4页 Chinese Journal of Modern Applied Pharmacy
基金 高等学校博士学科点专项科研基金(No20070062009)
关键词 缺氧/复氧损伤 联合用药 乳酸脱氢酶 超氧化物歧化酶 热休克蛋白 hypoxia/reoxygenation drug combination lactate dehydrogenase superoxide dismutase heat shock protein
  • 相关文献

参考文献11

  • 1MURPHY E,STEENBERGEN C.Mechanisms underlyingacute protection from cardiac ischemia-reperfusion injury[J].Physiol Rev,2008,88(2):581-609.
  • 2孔雁军,刘艳霞,娄建石.硝酸甘油与丁丙诺啡合用抗大鼠心肌缺血的药理性预适应研究[J].中国药理学通报,2003,19(12):1370-1375. 被引量:7
  • 3YANG C S,TSAI P J,CHOU S T,et al.The roles of reactiveoxygen species and endogenous opioid peptides in ischemiainduced arrhythmia of isolated rat hearts[J].Free Radic BiolMed,1995,18(3):593-598.
  • 4GAO F,YAO CL,GAO E.Enhancement of glutathionecardioprotection by ascorbic acid in myocardial reperfusioninjury[J].J Pharmacol Exp Ther,2002,301(12):543-550.
  • 5张焕基,许香广,张东辉,胡雪松,周文娟,吴施惠.冠状动脉内注射美托洛尔对介入性心肌损伤的保护作用[J].中国实用医药,2009,4(32):13-14. 被引量:4
  • 6GHEORGHIADE M,GOLDSTEIN S.-Blockers in thepost-myocardial infarction patient[J].Circulation,2002,106(4):394-398.
  • 7MAX LIYC.Glutamine against myocardial ischemia andreperfusion injury.中国动脉硬化杂志,2007,15(11):873-875.
  • 8SHENY LIANGZX.Effects of pinacidil postconditioningon the myocardial ischemia-reperfusion injury in rats.中西医结合心脑血管病杂志,2009,7(5):561-563.
  • 9KOWALTOWSKI A J,SEETHARAMAN S,PAUCEK P,etal.Bioenergetic consequences of opening the ATP-sensitiveK+channel of heart mitochondria[J].Am J Physiol Heart CircPhysiol,2001,280(2):H6492-57.
  • 10LU Z Q.The effect of Insulin to cardiovascular system[J].Drug Evaluation,2008,5(8):361-366.

二级参考文献30

  • 1颜士岩,张东生,郑杰.热休克蛋白在肿瘤治疗领域中的研究进展[J].医学研究生学报,2005,18(1):59-62. 被引量:6
  • 2王砚青,江时森,乐美兆,邱红.促红细胞生成素对大鼠心肌缺血-再灌注损伤的保护作用[J].医学研究生学报,2005,18(4):338-342. 被引量:18
  • 3娄建石,张海波,刘艳霞,朱险峰,张才丽.无创性心功能血流动力学计算机实时监测系统[J].中国药理学通报,1996,12(1):91-95. 被引量:8
  • 4Fen Wei Wang, Abdulfatah Osman, Javier Otero, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary-Blocker. Circulation, 2003, 107: 2914-2919.
  • 5T. B. Ferguson Jr, L P. Coombs, E.D. Peterson. Preoperative - blocker Use and mortality and morbidity following CABG surgery in north America. JAMA, 2002, 287(17) :2221-2226.
  • 6Mihai Gheorghimte, Sidney GoldsteirL Blockers in the Post-Myocardial Infarction Patient. Circulation, 2002,106:394 - 398.
  • 7Sharma SK, Kini A, Marmur JD, et aL Cardioprotective effect of prior-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation, 2000, 102: 166-172.
  • 8Stephen G. Ellis, Sorin J. Brener, A. Michael Lincoff, et aL Blockers before percutancous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation, 2001, 104 : 2685 -2688.
  • 9Sammut IA,Harrison JC.Cardiac mitochondrial complex activity is enhanced by heat shock proteins[J].Clin Exp Pharmacol Physicol,2003,30 (1-2):110-115.
  • 10van der Horst IC,Jimmer JR,Ottewangers JR,et al.Glucose-insulin-potassium and reperfusion in acute myocardial infarction:Rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)[J].Am Heart J,2005,149(4):585-591.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部